Tiger Medicine (stock code: 300347.SZ) announced its first quarter financial results, with a net profit attributable to shareholders of 165 million yuan, a decrease of 29.61%

Financial news from the Securities Times app: Taiji Pharmaceutical (300347.SZ) released its first quarter report for 2025. The company's operating income was 1.564 billion yuan, a decrease of 5.79% compared to the same period last year. Net profit attributable to shareholders of the listed company was 165 million yuan, a decrease of 29.61% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 102 million yuan, a decrease of 66.23% year-on-year. Basic earnings per share were 0.19 yuan.